by NEW DOSAGE FORMS
A new dosage form is defined as a drug product which is a different pharmaceutical product type, but contains the same active substance as included in the existing drug product approved by the pertinent regulatory authority.
Such pharmaceutical product types include products of different administration route (e.g., oral to parenteral), new specific functionality/delivery systems
(e.g., immediate release tablet to modified release tablet) and different dosage forms of the same administration route (e.g., capsule to tablet, solution to suspension).
Stability protocols for new dosage forms should follow the guidance in the parent stability guideline in principle. However, are duced stability data base at submission time (e.g., 6 months accelerated and 6 months long term data from ongoing studies)may be acceptable in certain justified cases.
